OaCP (oncology-and-cytogenetic-products) Fast Laboratory Diagnostics
Biologia, biotecnologie, chimica, diagnostica, oncologia, and citogenetica
OaCP , Oncology and Cytogenetic Products is an bio tech company from Italy who reduces the diagnostic time of cancer. OaCP provides CE approved and proprietary advanced diagnostic reagents that make 50% less costly and 97% faster DNA tests for cancer diagnosis using In Situ Hybridization. OaCP products also allow easier and faster RT PCR tests for Viral (eg. COVID-19), Microbiological and Cancer analysis.
Our objective is to provide oncology diagnostics laboratories and research institutions with fast FISH solutions that will disrupt cancer diagnosis times and costs. OaCP (oncology-and-cytogenetic-products) reduces cancer’ genetic tests time from 3 days to 2 hours and the cost by 50% with its chemical reagents.
OaCP has been conceived in 2015 as a project within the Bologna University Entrepreneurship Program (aka Launch Pad). We won the first edition of the Launch Pad Program and enrolled in the TVLP.co mindset program in Silicon Valley (Menlo Park, SF). One year later, OaCP was officially incorporated and was selected to take part in the RebelBio Accelerator Program in Cork (IE). Our company is headquartered in Ireland with an R&D dept. at the Bologna University, where we enjoy not only their world-class equipment and facilities but also maintain key industrial partnerships and collaboration with the University and research groups.
- $330 K total funding amount
- The global FIRST CE-IVD COVID-19 Nucleic Acid Detection Kit that simultaneously detect COVID-19 positivity and the presence of its main variants
- 14 awards for the efforts in molecular biology and in fast laboratory diagnostics.
- 2 Sales representatives in Italy and Japan
- 17 countries distribution network
- Team of professionals with 50+ years of experience combined
Co-Branding, Co-Sales, Distribution, PoC
Anywhere in the world
To reduce the lack of efficiency of DNA tests for cancer and infection
diseases diagnosis, we are looking for international distributors and leading companies in molecular biology to work with us around the world.
Enrico Di Oto
Co-founder & CEO